Healthpeak Properties, Inc. (NYSE:DOC) Stock Rated "Hold" by Sell-Side Brokerages

Key Points

• Analysts maintain a cautious outlook: Eighteen analysts give Healthpeak Properties an average “Hold” rating, with 14 holds and four buys. The average 12-month price target is $21.60 versus the stock’s reported $19.25 opening price.
• Healthpeak’s latest quarter exceeded expectations, with earnings per share of $0.08 versus the $0.03 consensus estimate and revenue of $771.58 million, up 11.1% year over year.
• The REIT offers a 6.3% dividend yield: It declared a monthly dividend of $0.1017 per share, or approximately $1.22 annualized, although its reported payout ratio is high at 348.57%.

Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been given an average recommendation of "Hold" by the eighteen analysts that are currently covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $21.60.

DOC has been the subject of several recent analyst reports. Mizuho upped their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a report on Monday, July 6th. Barclays dropped their target price on shares of Healthpeak Properties from $24.00 to $21.00 and set an "equal weight" rating on the stock in a report on Tuesday, October 13th. Citigroup boosted their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. Weiss Ratings lowered shares of Healthpeak Properties from a "hold (c+)" rating to a "hold (c)" rating in a research report on Wednesday, September 16th. Finally, Jefferies Financial Group restated a "hold" rating and set a $21.00 price target (down from $22.00) on shares of Healthpeak Properties in a report on Tuesday, September 15th.

Healthpeak Properties Stock Down 0.5%

Shares of DOC stock opened at $19.25 on Friday. The stock's 50 day simple moving average is $20.07 and its 200 day simple moving average is $19.95. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.95. The company has a market capitalization of $13.27 billion, a price-to-earnings ratio of 54.99, a PEG ratio of 2.38 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%. The firm had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. During the same period in the previous year, the company earned $0.46 EPS. The company's revenue for the quarter was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be paid a $0.1017 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.3%. Healthpeak Properties's payout ratio is presently 348.57%.

Hedge Funds Weigh In On Healthpeak Properties

Large investors have recently made changes to their positions in the business. Apollon Wealth Management LLC increased its position in Healthpeak Properties by 456.5% in the 3rd quarter. Apollon Wealth Management LLC now owns 55,383 shares of the real estate investment trust's stock worth $1,106,000 after buying an additional 45,431 shares during the period. Sigma Planning Corp boosted its position in shares of Healthpeak Properties by 28.1% in the third quarter. Sigma Planning Corp now owns 106,211 shares of the real estate investment trust's stock valued at $2,121,000 after acquiring an additional 23,289 shares during the period. Financial Management Professionals Inc. boosted its position in shares of Healthpeak Properties by 3,912.1% in the third quarter. Financial Management Professionals Inc. now owns 6,620 shares of the real estate investment trust's stock valued at $132,000 after acquiring an additional 6,455 shares during the period. Probity Advisors Inc. boosted its position in shares of Healthpeak Properties by 101.5% in the third quarter. Probity Advisors Inc. now owns 42,626 shares of the real estate investment trust's stock valued at $851,000 after acquiring an additional 21,474 shares during the period. Finally, Valley National Advisers Inc. grew its stake in shares of Healthpeak Properties by 291.6% in the third quarter. Valley National Advisers Inc. now owns 3,180 shares of the real estate investment trust's stock worth $64,000 after acquiring an additional 2,368 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.